The economy is hurting biotech companies

Funding to biotech companies are at the lowest level in a decade, with five companies filing for bankruptcy over the past month.

Those that are surviving are looking at a very uncertain future, as “Wall Street won’t finance them, and the pharmaceutical industry can’t buy all of them.”

This affects the research of new and promising treatments, which depends on the willingness of investors.

It’s another way patients are getting hurt in the grim economic climate.

topics: drugs, economy

Related posts:

1. How banning pharmaceutical gifts to doctors may be hurting the economy
2. "A cure for cancer could be one of the worst mistakes for the United States economy"
3. The economy and doctor’s visits
4. How will the economy affect the prospects for health reform?
5. What if the economy was treated like a sick patient?
6. Is fibromyalgia real, and if so, are drug companies profiting from the uncertainty of the disease?
7. Physicians and the economy

  Follow on Twitter   Subscribe

Tagged as: drugs, patient